Medtronic To Seek HDE For Activa To Treat Obsessive-Compulsive Disorder
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's pursuit of Activa deep-brain stimulation to treat chronic obsessive-compulsive disorder will serve as a springboard to the lucrative depression market, the company predicts
You may also be interested in...
Neurostim Treatment Shows Promise As Psychiatric Treatment, Doc Says
Implanting a device to stimulate the nervous system with electrical current promises to be as viable a treatment for psychiatric conditions as it has proven for movement disorders, according to Ali Rezai, MD, chair of the Cleveland Clinic Center for Neurological Restoration
Neurostim Treatment Shows Promise As Psychiatric Treatment, Doc Says
Implanting a device to stimulate the nervous system with electrical current promises to be as viable a treatment for psychiatric conditions as it has proven for movement disorders, according to Ali Rezai, MD, chair of the Cleveland Clinic Center for Neurological Restoration
Deep brain stimulation
Deep brain stimulation is "a treatment option" for patients suffering from Parkinson's disease with motor complications, new guidelines from the American Academy of Neurology suggest. The April 3 release of the guidelines was welcome news to Medtronic, which manufactures Activa, one of the deep brain stimulators on the market used to treat that condition. The firm is seeking to broaden the use of Activa to treat obsessive-compulsive disorder and depression (1"The Gray Sheet" April 4, 2005, p. 16)...